Bharat Biotech, Alopexx to collaborate for anti-microbial vaccine AV0328
Hyderabad-based vaccine maker Bharat Biotech and clinical-stage U.S. biotechnology firm Alopexx Inc. will collaborate to co-develop and commercialise anti-microbial vaccine AV0328 in India and other low income and lower middle-income countries. A proprietary broad-spectrum anti-microbial vaccine candidate of Alopexx, AV0328 is a synthetic vaccine designed to target poly N-acetyl glucosamine (PNAG) found on the surface…
Read More “Bharat Biotech, Alopexx to collaborate for anti-microbial vaccine AV0328” »